Results 41 to 50 of about 35,727 (251)
Brazilian Registry of Bone Biopsy (REBRABO): design, data elements and methodology [PDF]
, 2014 Introduction: Mineral bone disorder (MBD) is a common condition in chronic kidney disease (CKD) patients and causes significant morbidity and mortality.
Barreto, Fellype Carvalho +11 more
core +2 more sources
Prognostic importance of plasma total magnesium in a cohort of cats with azotemic chronic kidney disease [PDF]
, 2018 BACKGROUND: Hypomagnesemia is associated with increased mortality and renal function decline in humans with chronic kidney disease (CKD). Magnesium is furthermore inversely associated with fibroblast growth factor 23 (FGF23), an important prognostic ...
Andrukhova +81 more
core +2 more sources
A novel fluorescent probe-based flow cytometric assay for mineral-containing nanoparticles in serum
Scientific Reports, 2017 Calciprotein particles, nanoscale aggregates of insoluble mineral and binding proteins, have emerged as potential mediators of phosphate toxicity in patients with Chronic Kidney Disease.
Edward R. Smith +6 more
doaj +1 more source
Health Technology Assessment, 2021 Background: Bisphosphonates are contraindicated in patients with stage 4+ chronic kidney disease. However, they are widely used to prevent fragility fractures in stage 3 chronic kidney disease, despite a lack of good-quality data on their effects ...
Danielle E Robinson +13 more
doaj +1 more source
Bone Quality in Chronic Kidney Disease: Definitions and Diagnostics [PDF]
, 2017 PURPOSE OF REVIEW: In this paper, we review the epidemiology, diagnosis, and pathogenesis of fractures and renal osteodystrophy. RECENT FINDINGS: The role of bone quality in the pathogenesis of fracture susceptibility in chronic kidney disease ...
McNerny, Erin M.B., Nickolas, Thomas L.
core +1 more source
Chronic Kidney Disease—Mineral and Bone Disorder (CKD-MBD), from Bench to Bedside
Kidney and Dialysis, 2023 Chronic kidney disease—mineral and bone disorder (CKD-MBD) is a systemic disorder that increases the risk of morbidity and mortality in dialysis patients.
Kosaku Nitta +4 more
doaj +1 more source
How accurate is your sclerostin measurement?:Comparison between three commercially available sclerostin ELISA kits [PDF]
, 2016 Sclerostin, bone formation antagonist is in the spotlight as a potential biomarker for diseases presenting with associated bone disorders such as chronic kidney disease (CDK-MBD). Accurate measurement of sclerostin is therefore important.
Fisher, Emily +6 more
core +1 more source
Advanced Functional Materials, EarlyView.A hydrogel with dynamic cross‐links was formed by cross‐linking hyaluronic acid with curcumin‐preloaded, phenylboronic acid‐modified poly(amidoamine) dendrimers. This hydrogel exhibited excellent injectability and self‐healing ability, enabling controlled Cur release in response to low pH, high reactive oxygen species (ROS) generation, or mechanical ...
Junjie Liu +9 more
wiley +1 more source
[Chronic kidney disease - Mineral bone disorders: Physiopathology and guidelines].
La Revue de medecine interne, 2022 Dans l’insuffisance rénale chronique, la réduction du débit de filtration glomérulaire (limitant l’excrétion de phosphate), la diminution de synthèse du calcitriol et les nombreuses restrictions alimentaires impactent l’homéostasie phosphocalcique (hyperparathyroïdie secondaire, ostéodystrophie rénale).
Lavainne, F., Guillot, P., Figueres, L.
openaire +2 more sources
The Bone and Mineral Disorder in Patients Undergoing Chronic Peritoneal Dialysis [PDF]
, 2018 Disorders of mineral metabolism and bone disease are common complications in CKD patients. They are very complex and involve a number of feedback loops between the kidney, bone, intestine, and the vasculature associated with an increased morbidity and ...
Barbullushi, Myftar +3 more
core +1 more source